Prelude Therapeutics, Inc. (PRLD)

2.78 +0.51 (+22.47%) USD  |  NASDAQ  |  Feb 20, 16:00
2.78 0.00 (0.00%) After-Hours: 20:00
More

Prelude Therapeutics Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
BioLife Solutions, Inc. Upgrade
Immunome, Inc. Upgrade
Incyte Corp. Upgrade
Aclaris Therapeutics, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade